+91 22 24172311
Sections
Search
Subscribe
Equity
Venture Capital
Private Equity
M&A
Private Equity | 11 March 2013

Update: Temasek Invests In Premji Backed Healthcare Global Enterprises

by Paritosh Gajjar
 
@Paritosh
Singapore government’s investment vehicle, Temasek Holdings, has invested R140 Cr in South India headquartered Healthcare Global Enterprises (HCG), as stated by ET.

It also adds a valuation figure of HCG at R1,000 Cr with founder BS Ajaikumar holding back 26-28% stake.

With the latest round, Evolvence Capital, which had put in R30 Cr in the firm in 2007, has marked its exit with a return of around 2.3x.

The company is expected to double its network to 50 centers in India and Africa and also enter the multi-speciality space with the new funds.

Aditya Birla Fund To Buy Half Of Peninsula's Pune Project

Peninsula Land Limited, the listed realty developer of Ashok Piramal, is learnt to be selling 50% stake in its township project at Pune to Aditya Birla Group fund, according to ET.

Read More...

Ace Investor Rakesh Jhunjhunwala Backs Remedinet Technologies

Ace investor Rakesh Jhunjhunwala has invested an undisclosed amount in Remedinet Technologies, software firm which provides solutions to manage pre-authorised payments. The round also saw the participation of existing investors - Bessemer Venture Partners and Nirvana Venture Advisors Private Limited.

Read More...
TL Home Search New Keet
CONTACT US
Info@DealCurry.com
+91 22 24172311
A 311, 3rd Floor, AntopHill Warehousing Company,
Near Dosti Acres
Wadala(E),
Mumbai 400037
   
 
CLIENTS
USEFUL LINKS
SOLUTIONS
Copyright © EagleEye Research & Media Pvt. Ltd. 2009 All Rights Reserved - Interactive multimedia analysis platform for financial markets.
Site map |Terms of Use |Privacy Policy
DealCurry tracks financial and corporate markets for events, interprets and integrates the information in our platform, providing premium data, news and analytics. DealCurry provides comprehensive coverage of the capital markets through an intuitive, user-friendly interface.